Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Fox

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
"Cytokine storm" in the phase I trial of monoclonal antibody TGN1412: better understanding the causes to improve preclinical testing of immunotherapeuticsRichard Stebbings, Lucy Findlay, Cherry Edwards, et al.
International Journal of Surgical Pathology|January 15, 2020
A Malignant Neoplasm From the Jejunum With a <i>MALAT1-GLI1</i> Fusion and 26-Year Survival HistoryOwen William John Prall, Christopher Robert Edward McEvoy, David John Byrne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 6, 2019
Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic Agent Against Non Muscle-Invasive Bladder CancerNicola E Annels, David Mansfield, Mehreen Arif, et al.
Journal of Psychopharmacology (Oxford, England)|June 9, 2018
Joint BAP NAPICU evidence-based consensus guidelines for the clinical management of acute disturbance: De-escalation and rapid tranquillisationMaxine X Patel, Faisil N Sethi, Thomas Re Barnes, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
"Cytokine storm" in the phase I trial of monoclonal antibody TGN1412: better understanding the causes to improve preclinical testing of immunotherapeuticsRichard Stebbings, Lucy Findlay, Cherry Edwards, et al.
International Journal of Surgical Pathology|January 15, 2020
A Malignant Neoplasm From the Jejunum With a <i>MALAT1-GLI1</i> Fusion and 26-Year Survival HistoryOwen William John Prall, Christopher Robert Edward McEvoy, David John Byrne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 6, 2019
Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic Agent Against Non Muscle-Invasive Bladder CancerNicola E Annels, David Mansfield, Mehreen Arif, et al.
Journal of Psychopharmacology (Oxford, England)|June 9, 2018
Joint BAP NAPICU evidence-based consensus guidelines for the clinical management of acute disturbance: De-escalation and rapid tranquillisationMaxine X Patel, Faisil N Sethi, Thomas Re Barnes, et al.
Pageof 3